261 related articles for article (PubMed ID: 38022682)
1. Combination of verteporfin-photodynamic therapy with 5-aza-2'-deoxycytidine enhances the anti-tumour immune response in triple negative breast cancer.
Banerjee SM; Acedo P; El Sheikh S; Harati R; Meecham A; Williams NR; Gerard G; Keshtgar MRS; MacRobert AJ; Hamoudi R
Front Immunol; 2023; 14():1188087. PubMed ID: 38022682
[TBL] [Abstract][Full Text] [Related]
2. 5-Aza-2'-deoxycytidine potentiates antitumour immune response induced by photodynamic therapy.
Wachowska M; Gabrysiak M; Muchowicz A; Bednarek W; Barankiewicz J; Rygiel T; Boon L; Mroz P; Hamblin MR; Golab J
Eur J Cancer; 2014 May; 50(7):1370-81. PubMed ID: 24559534
[TBL] [Abstract][Full Text] [Related]
3. Remotely Phototriggered, Transferrin-Targeted Polymeric Nanoparticles for the Treatment of Breast Cancer.
Jadia R; Kydd J; Rai P
Photochem Photobiol; 2018 Jul; 94(4):765-774. PubMed ID: 29427385
[TBL] [Abstract][Full Text] [Related]
4. Photosensitive small extracellular vesicles regulate the immune microenvironment of triple negative breast cancer.
Ding YN; Ding HY; Li H; Yang R; Huang JY; Chen H; Wang LH; Wang YJ; Hu CM; An YL; Zhang ZY; Yu WP; Tang QS; Shao GL
Acta Biomater; 2023 Sep; 167():534-550. PubMed ID: 37302734
[TBL] [Abstract][Full Text] [Related]
5. Photodynamic treatment with purpurin 18 effectively inhibits triple negative breast cancer by inducing cell apoptosis.
Huang P; Zhang B; Yuan Q; Zhang X; Leung W; Xu C
Lasers Med Sci; 2021 Mar; 36(2):339-347. PubMed ID: 32623604
[TBL] [Abstract][Full Text] [Related]
6. Photodynamic therapy with zinc phthalocyanine enhances the anti-cancer effect of tamoxifen in breast cancer cell line: Promising combination treatment against triple-negative breast cancer?
Rajabi N; Mohammadnejad F; Doustvandi MA; Shadbad MA; Amini M; Tajalli H; Mokhtarzadeh A; Baghbani E; Silvestris N; Baradaran B
Photodiagnosis Photodyn Ther; 2023 Mar; 41():103212. PubMed ID: 36436735
[TBL] [Abstract][Full Text] [Related]
7. Synergistic effects of photodynamic therapy and chemotherapy: Activating the intrinsic/extrinsic apoptotic pathway of anoikis for triple-negative breast cancer treatment.
Zhang T; Wang X; Wang D; Lei M; Hu Y; Chen Z; Li Y; Luo Y; Zhang L; Zhu Y
Biomater Adv; 2024 Jun; 160():213859. PubMed ID: 38642515
[TBL] [Abstract][Full Text] [Related]
8. Verteporfin-based photodynamic therapy overcomes gemcitabine insensitivity in a panel of pancreatic cancer cell lines.
Celli JP; Solban N; Liang A; Pereira SP; Hasan T
Lasers Surg Med; 2011 Sep; 43(7):565-74. PubMed ID: 22057484
[TBL] [Abstract][Full Text] [Related]
9. CpG oligodeoxynucleotide as immune adjuvant enhances photodynamic therapy response in murine metastatic breast cancer.
Xia Y; Gupta GK; Castano AP; Mroz P; Avci P; Hamblin MR
J Biophotonics; 2014 Nov; 7(11-12):897-905. PubMed ID: 23922221
[TBL] [Abstract][Full Text] [Related]
10. Enhanced antitumor effects of BPD-MA-mediated photodynamic therapy combined with adriamycin on breast cancer in mice.
Tong ZS; Miao PT; Liu TT; Jia YS; Liu XD
Acta Pharmacol Sin; 2012 Oct; 33(10):1319-24. PubMed ID: 22842729
[TBL] [Abstract][Full Text] [Related]
11. Targeting tissue factor on tumour cells and angiogenic vascular endothelial cells by factor VII-targeted verteporfin photodynamic therapy for breast cancer in vitro and in vivo in mice.
Hu Z; Rao B; Chen S; Duanmu J
BMC Cancer; 2010 May; 10():235. PubMed ID: 20504328
[TBL] [Abstract][Full Text] [Related]
12. Nectin-4: a new prognostic biomarker for efficient therapeutic targeting of primary and metastatic triple-negative breast cancer.
M-Rabet M; Cabaud O; Josselin E; Finetti P; Castellano R; Farina A; Agavnian-Couquiaud E; Saviane G; Collette Y; Viens P; Gonçalves A; Ginestier C; Charafe-Jauffret E; Birnbaum D; Olive D; Bertucci F; Lopez M
Ann Oncol; 2017 Apr; 28(4):769-776. PubMed ID: 27998973
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic Enhancement of Verteporfin-mediated Photodynamic Therapy by mTOR Inhibitors.
Kraus D; Palasuberniam P; Chen B
Photochem Photobiol; 2020 Mar; 96(2):358-364. PubMed ID: 31769520
[TBL] [Abstract][Full Text] [Related]
14. Biomimetic oxygen delivery nanoparticles for enhancing photodynamic therapy in triple-negative breast cancer.
Fang H; Gai Y; Wang S; Liu Q; Zhang X; Ye M; Tan J; Long Y; Wang K; Zhang Y; Lan X
J Nanobiotechnology; 2021 Mar; 19(1):81. PubMed ID: 33743740
[TBL] [Abstract][Full Text] [Related]
15. Triple-negative breast cancer treatment in xenograft models by bifunctional nanoprobes combined to photodynamic therapy.
Dos Santos Jesus VP; Vieira PFA; Cintra RC; Sant'Anna LB; Zezell DM; Castilho ML; Raniero L
Photodiagnosis Photodyn Ther; 2022 Jun; 38():102796. PubMed ID: 35263669
[TBL] [Abstract][Full Text] [Related]
16. Combination of a novel heat shock protein 90-targeted photodynamic therapy with PD-1/PD-L1 blockade induces potent systemic antitumor efficacy and abscopal effect against breast cancers.
Kaneko K; Acharya CR; Nagata H; Yang X; Hartman ZC; Hobeika A; Hughes PF; Haystead TAJ; Morse MA; Lyerly HK; Osada T
J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36171008
[TBL] [Abstract][Full Text] [Related]
17. Adaptive antitumor immune response stimulated by bio-nanoparticle based vaccine and checkpoint blockade.
Bai X; Zhou Y; Yokota Y; Matsumoto Y; Zhai B; Maarouf N; Hayashi H; Carlson R; Zhang S; Sousa A; Sun B; Ghanbari H; Dong X; Wands JR
J Exp Clin Cancer Res; 2022 Apr; 41(1):132. PubMed ID: 35392977
[TBL] [Abstract][Full Text] [Related]
18. Preclinical comparison of mTHPC and verteporfin for intracavitary photodynamic therapy of malignant pleural mesothelioma.
Opitz I; Krueger T; Pan Y; Altermatt HJ; Wagnières G; Ris HB
Eur Surg Res; 2006; 38(3):333-9. PubMed ID: 16785733
[TBL] [Abstract][Full Text] [Related]
19. Comparison between endothelial and tumor cells in the response to verteporfin-photodynamic therapy and a PI3K pathway inhibitor.
Fateye B; Wan A; Yang X; Myers K; Chen B
Photodiagnosis Photodyn Ther; 2015 Mar; 12(1):19-26. PubMed ID: 25636781
[TBL] [Abstract][Full Text] [Related]
20. Small molecule kinase inhibitors enhance aminolevulinic acid-mediated protoporphyrin IX fluorescence and PDT response in triple negative breast cancer cell lines.
Palasuberniam P; Kraus D; Mansi M; Howley R; Braun A; Myers K; Chen B
J Biomed Opt; 2021 Sep; 26(9):. PubMed ID: 34545713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
